Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression

Molecular Biology of the Cell

Volumn 19, Issue 9, 2008, Pages 3745-3757

  Turner, David P ^a   Findlay, Victoria J ^a   Kirven, A Darby ^b   Moussa, Omar ^a   Watson, Dennis K ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b South Carolina Governor's School for Science and Mathematics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIM PROTEIN; PROTEIN SH3; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL ADHESION; CELL JUNCTION; CELL MIGRATION; CONTROLLED STUDY; FOCAL ADHESION; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETON; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-ETS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR;

EID: 55549124562     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E08-02-0154     Document Type: Article

References (67)

1. Abu-Ali, S., Sugiura, T., Takahashi, M., Shiratsuchi, T., Ikari, T., Seki, K., Hiraki, A., Matsuki, R., and Shirasuna, K. (2005). Expression of the urokinase receptor regulates focal adhesion assembly and cell migration in adenoid cystic carcinoma cells. J. Cell Physiol. 203, 410-419.
2. Aguirre Ghiso, J. A., Alonso, D. F., Farias, E. F., Gomez, D. E., and de Kier Joffe, E. B. (1999). Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. Eur. J. Biochem. 263, 295-304.
3. Bailly, M., Yan, L., Whitesides, G. M., Condeelis, J. S., and Segall, J. E. (1998). Regulation of protrusion shape and adhesion to the substratum during chemotactic responses of mammalian carcinoma cells. Exp. Cell Res. 241, 285-299.
4. Bear, J. E. et al. (2002). Antagonism between Ena/VASP proteins and actin filament capping regulates fibroblast motility. Cell 109, 509-521.
5. Behrens, P., Rothe, M., Wellmann, A., Krischler, J., and Wernert, N. (2001). The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J. Pathol. 194, 43-50.
6. Benz, C. C. et al. (1997). HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene 15, 1513-1525.
7. Bieche, I., Tozlu, S., Girault, I., Onody, P., Driouch, K., Vidaud, M., and Lidereau, R. (2004). Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, NRG1 and CGB expression. Carcinogenesis 25, 405-411.
8. Blasi, F., and Carmeliet, P. (2002). uPAR: a versatile signalling orchestrator. Nat. Rev. Mol. Cell Biol. 3, 932-943.
9. Bosc, D. G., Goueli, B. S., and Janknecht, R. (2001). HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1. Oncogene 20, 6215-6224.
10. Buggy, Y., Maguire, T. M., McDermott, E., Hill, A. D., O'Higgins, N., and Duffy, M. J. (2006). Ets2 transcription factor in normal and neoplastic human breast tissue. Eur. J. Cancer 42, 485-491.
11. Buggy, Y., Maguire, T. M., McGreal, G., McDermott, E., Hill, A. D., O'Higgins, N., and Duffy, M. J. (2004). Overexpression of the Ets-1 transcription factor in human breast cancer. Br. J. Cancer 91, 1308-1315.
12. Chapman, H. A., and Wei, Y. (2001). Protease crosstalk with integrins: the urokinase receptor paradigm. Thromb. Haemost. 86, 124-129.
13. Choong, P. F., and Nadesapillai, A. P. (2003). Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis. Clin. Orthop. Relat. Res. S46-S58.
14. Compagni, A., and Christofori, G. (2000). Recent advances in research on multistage tumorigenesis. Br. J. Cancer 83, 1-5.
15. D'Orazio, D., Besser, D., Marksitzer, R., Kunz, C., Hume, D. A., Kiefer, B., and Nagamine, Y. (1997). Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2. Gene 201, 179-187.
16. Danuser, G. (2005). Coupling the dynamics of two actin networks-new views on the mechanics of cell protrusion. Biochem. Soc. Trans. 33, 1250-1253.
17. Doane, A. S., Danso, M., Lal, P., Donaton, M., Zhang, L., Hudis, C., and Gerald, W. L. (2006). An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene 25, 3994-4008.
18. Draghici, S., Khatri, P., Tarca, A. L., Amin, K., Done, A., Voichita, C., Georgescu, C., and Romero, R. (2007). A systems biology approach for pathway level analysis. Genome Res. 17, 1537-1545.
19. Dudoit, S., Gentleman, R. C., and Quackenbush, J. (2003). Open source software for the analysis of microarray data. Biotechniques Suppl. 45-51.
20. Feldman, R. J., Sementchenko, V. I., Gayed, M., Fraig, M. M., and Watson, D. K. (2003). Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression. Cancer Res. 63, 4626-4631.
21. Festuccia, C., Angelucci, A., Gravina, G. L., Biordi, L., Millimaggi, D., Muzi, P., Vicentini, C., and Bologna, M. (2005). Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination. Thromb. Haemost. 93, 964-975.
22. Fidler, I. J. (2003). The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 3, 453-458.
23. Friedl, P., and Wolf, K. (2003). Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 3, 362-374.
24. Geller, S. C., Gregg, J. P., Hagerman, P., and Rocke, D. M. (2003). Transformation and normalization of oligonucleotide microarray data. Bioinformatics 19, 1817-1823.
25. Ghadersohi, A., Odunsi, K., Lele, S., Collins, Y., Greco, W. R., Winston, J., Liang, P., and Sood, A. K. (2004). Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules. Oncol. Rep. 11, 453-458.
26. Ghadersohi, A., Pan, D., Fayazi, Z., Hicks, D. G., Winston, J. S., and Li, F. (2006). Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo. Breast Cancer Res. Treat.
27. Ghadersohi, A., and Sood, A. K. (2001). Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen. Clin. Cancer Res. 7, 2731-2738.
28. Grunewald, T. G., Kammerer, U., Kapp, M., Eck, M., Dietl, J., Butt, E., and Honig, A. (2007a). Nuclear localization and cytosolic overexpression of LASP-1 correlates with tumor size and nodal-positivity of human breast carcinoma. BMC Cancer 7, 198.
29. Grunewald, T. G., Kammerer, U., Schulze, E., Schindler, D., Honig, A., Zimmer, M., and Butt, E. (2006). Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells. Exp. Cell Res. 312, 974-982.
30. Grunewald, T. G., Kammerer, U., Winkler, C., Schindler, D., Sickmann, A., Honig, A., and Butt, E. (2007b). Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation. Br. J. Cancer 96, 296-305.
31. Gu, X., Zerbini, L. F., Otu, H. H., Bhasin, M., Yang, Q., Joseph, M. G., Grall, F., Onatunde, T., Correa, R. G., and Libermann, T. A. (2007). Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells. Cancer Res. 67, 4219-4226.
32. Gupton, S. L., and Waterman-Storer, C. M. (2006). Spatiotemporal feedback between actomyosin and focal-adhesion systems optimizes rapid cell migration. Cell 125, 1361-1374.
33. Han, B., Nakamura, M., Mori, I., Nakamura, Y., and Kakudo, K. (2005). Urokinase-type plasminogen activator system and breast cancer. Oncol. Rep. 14, 105-112.
34. Harris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., Somerfield, M. R., Hayes, D. F., and Bast, R. C., Jr. (2007). American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J. Clin. Oncol. 25, 5287-5312.
35. Holt, M. R., Critchley, D. R., and Brindle, N. P. (1998). The focal adhesion phosphoprotein, VASP. Int. J. Biochem. Cell Biol. 30, 307-311.
36. Kedrin, D., van Rheenen, J., Hernandez, L., Condeelis, J., and Segall, J. E. (2007). Cell motility and cytoskeletal regulation in invasion and metastasis. J. Mammary Gland Biol. Neoplasia 12, 143-152.
37. Khatri, P., Sellamuthu, S., Malhotra, P., Amin, K., Done, A., and Draghici, S. (2005). Recent additions and improvements to the Onto-Tools. Nucleic Acids Res. 33, W762-W765.
38. Khatri, P., Voichita, C., Kattan, K., Ansari, N., Khatri, A., Georgescu, C., Tarca, A. L., and Draghici, S. (2007). Onto-Tools: new additions and improvements in 2006. Nucleic Acids Res. 35, W206-W211.
39. Kjoller, L. (2002). The urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motility. Biol. Chem. 383, 5-19.
40. Krause, M., Bear, J. E., Loureiro, J. J., and Gertler, F. B. (2002). The Ena/VASP enigma. J. Cell Sci. 115, 4721-4726.
41. Krause, M., Dent, E. W., Bear, J. E., Loureiro, J. J., and Gertler, F. B. (2003). Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu. Rev. Cell Dev. Biol. 19, 541-564.
42. Kruger, A., Soeltl, R., Lutz, V., Wilhelm, O. G., Magdolen, V., Rojo, E. E., Hantzopoulos, P. A., Graeff, H., Gansbacher, B., and Schmitt, M. (2000). Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87). Cancer Gene Ther. 7, 292-299.
43. Li, B., Zhuang, L., and Trueb, B. (2004). Zyxin interacts with the SH3 domains of the cytoskeletal proteins LIM-nebulette and Lasp-1. J. Biol. Chem. 279, 20401-20410.
44. Lin, Y. H., Park, Z. Y., Lin, D., Brahmbhatt, A. A., Rio, M. C., Yates, J. R., 3rd, and Klemke, R. L. (2004). Regulation of cell migration and survival by focal adhesion targeting of Lasp-1. J. Cell Biol. 165, 421-432.
45. Loberg, R. D., Bradley, D. A., Tomlins, S. A., Chinnaiyan, A. M., and Pienta, K. J. (2007). The lethal phenotype of cancer: the molecular basis of death due to malignancy. CA Cancer J. Clin. 57, 225-241.
46. McLean, G. W., Carragher, N. O., Avizienyte, E., Evans, J., Brunton, V. G., and Frame, M. C. (2005). The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat. Rev. Cancer 5, 505-515.
47. Mogilner, A. (2006). On the edge: modeling protrusion. Curr. Opin. Cell Biol. 18, 32-39.
48. Nakada, M., Yamashita, J., Okada, Y., and Sato, H. (1999). Ets-1 positively regulates expression of urokinase-type plasminogen activator (uPA) and invasiveness of astrocytic tumors. J. Neuropathol. Exp. Neurol. 58, 329-334.
49. Nasiadka, A., and Krause, H. M. (1999). Kinetic analysis of segmentation gene interactions in Drosophila embryos. Development 126, 1515-1526.
50. Nowak, D. E., Tian, B., and Brasier, A. R. (2005). Two-step cross-linking method for identification of NF-kappaB gene network by chromatin immunoprecipitation. Biotechniques 39, 715-725.
51. Nozawa, M., Yomogida, K., Kanno, N., Nonomura, N., Miki, T., Okuyama, A., Nishimune, Y., and Nozaki, M. (2000). Prostate-specific transcription factor hPSE is translated only in normal prostate epithelial cells. Cancer Res. 60, 1348-1352.
52. Ossowski, L., and Aguirre-Ghiso, J. A. (2000). Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr. Opin. Cell Biol. 12, 613-620.
53. Pantaloni, D., Le Clainche, C., and Carlier, M. F. (2001). Mechanism of actin-based motility. Science 292, 1502-1506.
54. Ramakers, C., Ruijter, J. M., Deprez, R. H., and Moorman, A. F. (2003). Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett. 339, 62-66.
55. Reinhard, M., Jarchau, T., and Walter, U. (2001). Actin-based motility: stop and go with Ena/VASP proteins. Trends Biochem. Sci. 26, 243-249.
56. Sandmann, T., Jensen, L. J., Jakobsen, J. S., Karzynski, M. M., Eichenlaub, M. P., Bork, P., and Furlong, E. E. (2006). A temporal map of transcription factor activity: mef2 directly regulates target genes at all stages of muscle development. Dev. Cell 10, 797-807.
57. Schreiber, V., Moog-Lutz, C., Regnier, C. H., Chenard, M. P., Boeuf, H., Vonesch, J. L., Tomasetto, C., and Rio, M. C. (1998). Lasp-1, a novel type of actin-binding protein accumulating in cell membrane extensions. Mol. Med. 4, 675-687.
58. Seth, A., and Watson, D. K. (2005). ETS transcription factors and their emerging roles in human cancer. Eur. J. Cancer 41, 2462-2478.
59. Sporn, M. B. (1996). The war on cancer. Lancet 347, 1377-1381.
60. Tsujimoto, Y., Nonomura, N., Takayama, H., Yomogida, K., Nozawa, M., Nishimura, K., Okuyama, A., Nozaki, M., and Aozasa, K. (2002). Utility of immunohistochemical detection of prostate-specific Ets for the diagnosis of benign and malignant prostatic epithelial lesions. Int. J. Urol. 9, 167-172.
61. Turner, D. P., Findlay, V. J., Moussa, O., and Watson, D. K. (2007a). Defining ETS transcription regulatory networks and their contribution to breast cancer progression. J. Cell Biochem. 102, 549-559.
62. Turner, D. P., Moussa, O., Sauane, M., Fisher, P. B., and Watson, D. K. (2007b). Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer. Cancer Res. 67, 1618-1625.
63. Turner, D. P., and Watson, D. K. (2008). ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer. Expert Rev. Anticancer Ther. 8, 33-42.
64. Watabe, T., Yoshida, K., Shindoh, M., Kaya, M., Fujikawa, K., Sato, H., Seiki, M., Ishii, S., and Fujinaga, K. (1998). The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int. J. Cancer 77, 128-137.
65. Wehrle-Haller, B., and Imhof, B. (2002). The inner lives of focal adhesions. Trends Cell Biol. 12, 382-389.
66. Yamazaki, D., Kurisu, S., and Takenawa, T. (2005). Regulation of cancer cell motility through actin reorganization. Cancer Sci. 96, 379-386.
67. Yordy, J. S., Moussa, O., Pei, H., Chaussabel, D., Li, R., and Watson, D. K. (2005). SP100 inhibits ETS1 activity in primary endothelial cells. Oncogene 24, 916-931.